Browse studies

Find your next paid study

2,803 recruiting studies matching your filters

A Multi-centre, Randomised, Double-blind, Placebo-controlled, Phase IIIb Trial to Evaluate the Effect of Survodutide on Cardiac Structure and Function of Participants With Overweight or Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); (ELEVATE-LIVER)

This study is for adults aged 18 years and older who have a type of fatty liver disease called metabolic dysfunction-associated steatotic liver disease (MASLD)…

ObesityMetabolic Dysfunction-associated Steatotic Liver Disease

Estimated

~$10 – $7,500

Boehringer IngelheimNCT07850063

Phase 1

Proof-of-concept Study of Nicotinamide and Oral Tetrahydrouridine (THU) and Decitabine to Treat High Risk Sickle Cell Disease

A randomized control trial in 20 subjects with sickle cell disease comparing oral THU-decitabine to nicotinamide and in combination (THU, decitabine and nicoti…

Sickle Cell Disease

Estimated

~$10 – $8,750

EpiDestiny, Inc.NCT04055818

Phase 3

A Phase 3, Multicenter, Randomized, Open-Label Trial Investigating the Safety, Tolerability and Efficacy of Palopegteriparatide Administered Subcutaneously Daily at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

This trial has a treatment duration of 78 weeks and will include adult participants already on treatment with palopegteriparatide at doses at or greater than 3…

HypoparathyroidismEndocrine System DiseasesParathyroid Diseases

Estimated

~$10 – $8,750

Ascendis Pharma Bone Diseases A/SNCT07081997

Phase 2

A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants With COPD

This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will …

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $8,750

Expedition Therapeutics, IncNCT07684820

Understanding Neural Mechanisms Underlying Visual Hallucinations in Lewy Body Diseases

The goal of this basic experimental study involving humans (BESH) protocol is to improve the understanding of neural mechanisms underlying visual hallucination…

Lewy Body DiseaseLewy Body DementiaParkinson Disease+2 more

Estimated

~$10 – $1,125

NYU Langone HealthNCT07849413

Phase 4

Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy

This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer. Prosta…

Androgen Deprivation TherapyProstate CancerHypertension+2 more

Estimated

~$10 – $6,250

Virginia Commonwealth UniversityNCT07848828

Phase 4

A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, …

Ulcerative ColitisCrohn's Disease

EASi-PROTKT™ - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and…

Diabetes Mellitus, Type 2HypertensionCardiovascular Diseases

Estimated

~$10 – $7,500

Boehringer IngelheimNCT07064473

Texas Regional Excellence in Cancer (TREC) @Texas A&M University Cancer Prevention Registry and Repository

This study collects health and genetic information to implement cancer prevention and treatment strategies.

CancerGeneticsDisease+2 more

Estimated

~$10 – $750

Texas A&M UniversityNCT06826014

Phase 3

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy

Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that b…

Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients und…

Coronary Artery DiseaseHigh Risk Percutaneous Coronary InterventionInterventional Cardiology+1 more

Estimated

~$10 – $7,500

Supira MedicalNCT07296744

Oral Specimen and Data Acquisition Study of Subjects Requiring Third Molar Removal

Background: \- The third molars (wisdom teeth) normally grow in during late adolescence or early adulthood. Many people need or choose to have these teeth rem…

StomatognaticTooth DiseasesDiseases+2 more

Estimated

~$10 – $675

National Institute of Dental and Craniofacial Research (NIDCR)NCT01805869